We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$526M
AUM Growth
+$12.7M
Cap. Flow
-$17.8M
Cap. Flow %
-3.38%
Top 10 Hldgs %
29.77%
Holding
434
New
37
Increased
168
Reduced
187
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 7.14%
2 Healthcare 3.6%
3 Financials 3.08%
4 Consumer Discretionary 2.64%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
301
Deere & Co
DE
$164B
$300K 0.06%
849
-27
-3% -$9.86K
UGI icon
302
UGI
UGI
$7.29B
$298K 0.06%
6,442
-72
-1% -$3.24K
DOCU
303
DocuSign
DOCU
$11.4B
$293K 0.06%
1,050
-63
-6% -$14.1K
GD icon
304
General Dynamics
GD
$107B
$291K 0.06%
1,547
+234
+18% +$44.1K
CAT icon
305
Caterpillar
CAT
$385B
$288K 0.05%
1,325
-169
-11% -$39K
HNDL icon
306
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$635M
$288K 0.05%
11,238
+2,840
+34% +$71.8K
SO icon
307
Southern Company
SO
$105B
$288K 0.05%
4,751
+263
+6% +$16.8K
GILD icon
308
Gilead Sciences
GILD
$165B
$287K 0.05%
4,162
+633
+18% +$42.3K
FEP icon
309
First Trust Europe AlphaDEX Fund
FEP
$531M
$286K 0.05%
6,667
-79
-1% -$3.43K
TWLO icon
310
Twilio
TWLO
$38B
$279K 0.05%
710
-17
-2% -$5.9K
FNK icon
311
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
$273K 0.05%
+6,091
New +$275K
XLRN
312
DELISTED
Acceleron Pharma
XLRN
$272K 0.05%
2,168
-71
-3% -$8.96K
TMFS icon
313
Motley Fool Small-Cap Growth ETF
TMFS
$60M
$271K 0.05%
6,769
-2,118
-24% -$80.8K
ATO icon
314
Atmos Energy
ATO
$28.4B
$265K 0.05%
2,754
-31
-1% -$3.11K
OEF icon
315
iShares S&P 100 ETF
OEF
$20.5B
$265K 0.05%
1,343
-532
-28% -$101K
SBUX icon
316
Starbucks
SBUX
$119B
$263K 0.05%
2,343
-371
-14% -$41.9K
XEL icon
317
Xcel Energy
XEL
$48B
$263K 0.05%
3,994
+222
+6% +$15.5K
ARKG icon
318
ARK Genomic Revolution ETF
ARKG
$1.78B
$259K 0.05%
+2,797
New +$238K
MET icon
319
MetLife
MET
$61.7B
$259K 0.05%
4,330
-12,792
-75% -$811K
DJD icon
320
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$498M
$258K 0.05%
+5,848
New +$259K
EMR icon
321
Emerson Electric
EMR
$88.5B
$258K 0.05%
2,678
+6
+0.2% +$564
NXRT
322
NexPoint Residential Trust
NXRT
$641M
$256K 0.05%
4,659
+99
+2% +$5.09K
EUFN icon
323
iShares MSCI Europe Financials ETF
EUFN
$4.29B
$255K 0.05%
13,030
+99
+0.8% +$2.01K
SHM icon
324
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$255K 0.05%
5,152
-683
-12% -$33.9K
EVRG icon
325
Evergy
EVRG
$18.9B
$254K 0.05%
4,198
-53
-1% -$3.32K

Similar funds

Calton & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Calton & Associates held 434 positions worth $526M, up 2.5% from $514M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Calton & Associates withdrew a net $17.8M in Q2 2021, closing 28 positions and reducing 187 holdings. Its most notable exit was iShares Morningstar Mid-Cap Growth ETF, an estimated $1.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calton & Associates opened a new position in iShares iBonds 2023 Term High Yield and Income ETF worth $2.73M.

  • Calton & Associates's largest Q2 2021 buy was iShares iBonds 2023 Term High Yield and Income ETF: 110,245 shares worth $2.73M.
  • Calton & Associates added most to iShares Floating Rate Bond ETF in Q2 2021, an estimated $2.71M increase.
  • Calton & Associates's biggest Q2 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $7.44M.
  • Calton & Associates fully exited iShares Morningstar Mid-Cap Growth ETF in Q2 2021, selling an estimated $1.21M.
  • Calton & Associates's ten largest holdings make up 30% of its $526M portfolio in Q2 2021.
  • Calton & Associates opened 37 new positions and closed 28 in Q2 2021.
  • Calton & Associates's portfolio value rose 2.5% quarter-over-quarter to $526M.

Based on Calton & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.